Deng, Y;
              
      
            
                Chatterjee, B;
              
      
            
                Zens, K;
              
      
            
                Zdimerova, H;
              
      
            
                Müller, A;
              
      
            
                Schuhmachers, P;
              
      
            
                Ligeon, L-A;
              
      
            
            
          
      
            
            
          
      
            
            
          
      
            
            
          
      
            
            
          
      
            
            
          
      
            
            
            ... Münz, C; + view all
            
          
      
        
        
        
    
  
(2021)
  CD27 is required for protective lytic EBV antigen-specific CD8+ T-cell expansion.
Blood
, 137
       (23)
    
     pp. 3225-3236.
    
         10.1182/blood.2020009482.
  
  
       
    
  
| Preview | Text BLD-2020-009482R1-A manuscript 250321.pdf - Accepted Version Download (32MB) | Preview | 
Abstract
Primary immunodeficiencies in the costimulatory molecule CD27 and its ligand, CD70, predispose for pathologies of uncontrolled Epstein-Barr virus (EBV) infection in nearly all affected patients. We demonstrate that both depletion of CD27+ cells and antibody blocking of CD27 interaction with CD70 cause uncontrolled EBV infection in mice with reconstituted human immune system components. While overall CD8+ T-cell expansion and composition are unaltered after antibody blocking of CD27, only some EBV-specific CD8+ T-cell responses, exemplified by early lytic EBV antigen BMLF1-specific CD8+ T cells, are inhibited in their proliferation and killing of EBV-transformed B cells. This suggests that CD27 is not required for all CD8+ T-cell expansions and cytotoxicity but is required for a subset of CD8+ T-cell responses that protect us from EBV pathology.
| Type: | Article | 
|---|---|
| Title: | CD27 is required for protective lytic EBV antigen-specific CD8+ T-cell expansion | 
| Location: | United States | 
| Open access status: | An open access version is available from UCL Discovery | 
| DOI: | 10.1182/blood.2020009482 | 
| Publisher version: | http://dx.doi.org/10.1182/blood.2020009482 | 
| Language: | English | 
| Additional information: | This version is the author accepted manuscript. For information on re-use, please refer to the publisher’s terms and conditions. | 
| Keywords: | CD27, CD39, DLBCL, Epstein-Barr virus, IMMUNOBIOLOGY/B-cell neoplasms, IMMUNOBIOLOGY/Cytotoxic T cells, IMMUNOBIOLOGY/Host-pathogen interactions, IMMUNOBIOLOGY/T-Cell Mediated Immunity, IMMUNOBIOLOGY/T-cell costimulation, humanized mice | 
| UCL classification: | UCL UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences > Faculty of Medical Sciences UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences > Faculty of Medical Sciences > Div of Infection and Immunity | 
| URI: | https://discovery.ucl.ac.uk/id/eprint/10129568 | 
Archive Staff Only
|  | View Item | 
 
                      
